Fundz

Redwoods Acquisition completes PIPE agreement to support approved ANEW Medical deal

PRIVATEJun 14, 2024

Acquiring Company

HCM II Acquisition

Acquired Company

ANEW Medical

District Of ColumbiaOmahaFinancial ServicesVenture CapitalBiotechnologyHealth Care

Description

Redwoods Acquisition has finalized a PIPE agreement with Meteora Capital Partners and affiliates to purchase up to 1 million shares, securing funds to support the approved merger with ANEW Medical. The merger agreement originally included terms for ANEW to receive up to $60 million in stock, with a focus on developing disruptive therapies for neurodegenerative diseases.

Quick answer

HCM II Acquisition is acquiring ANEW Medical, announced June 14, 2024. HCM II Acquisition is based in District Of Columbia, United States.

How much did HCM II Acquisition pay for ANEW Medical?
The deal value was not disclosed.
What does HCM II Acquisition do?
HCM II Acquisition Corp. is a special-purpose acquisition company.
Where are HCM II Acquisition and ANEW Medical based?
HCM II Acquisition is based in District Of Columbia, United States. ANEW Medical is based in Omaha, Nebraska, United States.
Who are the decision-makers at HCM II Acquisition?
Fundz holds 4 contacts at HCM II Acquisition. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at HCM II Acquisition, and when

When HCM II Acquisition changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day HCM II Acquisition raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HCM II Acquisition, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HCM II Acquisition. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HCM II Acquisition

Location

100 F Street Northeast

District Of Columbia, United States

About

HCM II Acquisition Corp. is a special-purpose acquisition company. It focuses on acquiring companies in various industries. The firm aims to support growth for the acquired entities. They are listed on Nasdaq under the symbol HOND.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HCM II Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Matthew
Likely contact at this company
••••••••@••••••••

See Matthew's verified email →

Adriana
Likely contact at this company
••••••••@••••••••

See Adriana's verified email →

Stephanie
Senior decision-maker at this company
••••••••@••••••••

See Stephanie's verified email →

Kin
Likely contact at this company
••••••••@••••••••

See Kin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for HCM II Acquisition's next move

Learn about Strategic plan

Frequently asked

Who acquired ANEW Medical?

ANEW Medical was acquired by HCM II Acquisition, based in District Of Columbia. The deal was reported on June 14, 2024. HCM II Acquisition Corp. is a special-purpose acquisition company. It focuses on acquiring companies in various industries. The firm aims to support growth for the acquired entities. HCM II Acquisition is privately held and operates in Financial Services.

When did HCM II Acquisition acquire ANEW Medical?

HCM II Acquisition's acquisition of ANEW Medical was reported on June 14, 2024. Redwoods Acquisition has finalized a PIPE agreement with Meteora Capital Partners and affiliates to purchase up to 1 million shares, securing funds to support the approved merger with ANEW Medical. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does ANEW Medical do?

ANEW Medical is an early-stage biotechnology company focused on developing disruptive new therapies to treat neurodegenerative diseases. It is currently listed on the OTC Markets under the symbol LEAS. It is privately held, operating in Biotechnology, and is based in Omaha.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.